Bascule Biosciences, Inc.

Biotech New Rochelle, NY

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
New Rochelle, NY
Street
155 Stratton Road
Zip
10804

Offering

Total offering
$250k
Amount sold
$250k
First sale
Mar 25, 2026
Min investment
$0
Securities
Other
Federal exemption
Rule 506(b)
Investors so far
1

How this filing compares

Ranked #42 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.1× the median.

Other New York filings this week: AM-0316 Fund I, a series of Nebular Expansion, LP, Ascendancy Fund, LP, Bayberry Onshore Fund LP, CanAm PIDC Regional Center, LP XXXVIII, COMMUNITY DEVELOPMENT TRUST INC

Leadership

Aafia Chaudhry — Executive Officer (also: Director)

Filing details

Bascule Biosciences, Inc. filed a Form D with the SEC on April 2, 2026.

Other newest Biotech companies

Other newest companies in New York